English
Regional settings| Spread | 0.0179 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | -0.026179% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ $5,000.00 Short position overnight fee ~ $4,000.00 | 0.003957% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | USD | ||||
| Min traded quantity | 0.1 | ||||
| Margin | 20 | ||||
| Stock exchange | United States of America | ||||
| Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 0.5347 |
| Open | 0.538 |
| 1-Year Change | -61.12% |
| Day's Range | 0.5204 - 0.538 |
Dynatronics Corporation is a medical device company that is focused on providing restorative products. The Company designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Its products include BODYICE cold pack wraps, DELUXE BODYICE, DYNAFLEX foam, DYNAFLEX spun lace, DYNAFLEX brown electrodes, DYNAGEL ultrasound gel, DYNAHEAT custom terry covers (foam filled), DYNAHEAT moist hot packs, DYNATRON 125 ultrasound, DYNATRON SOLARIS plus lead wires, and DYNATRON SOLARIS PLUS THERMOSTIM probe. Through its distribution channels, the Company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The Company products are marketed under a portfolio of brands, including Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM among others.
BRIEF: For the six months ended 31 December 2021, Dynatronics Corporation revenues decreased 5% to $22.8M. Net loss applicable to common stockholders decreased 10% to $1.3M. Revenues reflect Orthopedic Soft Bracing and Support Products segment decrease of 8% to $10.7M, Physical Therapy and Rehabilitation Products segment decrease of 2% to $12.1M. Lower net loss reflects Other income, net increase from $3K to $955K (income), Selling/General/Admin.
Common Stock no Par, 2/11, 50M auth., 13,383,832 issd. Insiders control 33.81%. PO: 11/83, 3,597,444 shares @ $.81 by the Company. 12/12, 1-for-5 reverse stock split.
